tiprankstipranks
Context Therapeutics (CNTX)
NASDAQ:CNTX

Context Therapeutics (CNTX) Financial Statements

63 Followers

Context Therapeutics Financial Overview

Context Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.335; its P/E ratio is -1.65; Context Therapeutics is scheduled to report earnings on August 8, 2024, and the estimated EPS forecast is $-0.07. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -3.82M$ -6.93M$ -6.17M$ -5.30M$ -6.31M
EBITDA$ -3.82M$ -6.93M-$ -5.28M$ -6.28M
Net Income Common Stockholders$ -3.67M$ -6.77M$ -5.87M$ -5.01M$ -6.31M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 10.10M$ 14.40M$ 21.70M$ 25.10M$ 29.80M
Total Assets$ 11.05M$ 16.06M$ 22.99M$ 27.72M$ 31.97M
Total Debt$ 0.00$ 0.00$ 0.00$ 7.97K$ 31.67K
Net Debt$ -10.10M$ -14.40M$ -21.70M$ -25.09M$ -29.77M
Total Liabilities$ 2.61M$ 4.19M$ 4.60M$ 3.76M$ 3.23M
Stockholders Equity$ 8.44M$ 11.87M$ 18.38M$ 24.01M$ 28.73M
Cash Flow-
Free Cash Flow$ -4.36M$ -7.23M-$ -4.63M$ -5.73M
Operating Cash Flow$ -4.36M$ -7.23M$ -3.46M$ -4.63M$ -5.73M
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Context Therapeutics Earnings and Revenue History

Context Therapeutics Debt to Assets

Context Therapeutics Cash Flow

Context Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis